Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Cadila gains on arm getting USFDA's nod for Minocycline Hydrochloride tablets

24-Nov2017

Cadila gains on arm getting USFDA's nod for Minocycline Hydrochloride tablets

Cadila Healthcare is currently trading at Rs. 446.85, up by 3.35 points or 0.76% from its previous closing of Rs. 443.50 on the BSE.

The scrip opened at Rs. 443.20 and has touched a high and low of Rs. 450.40 and Rs. 442.20 respectively. So far 32508 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 558.00 on 12-Jun-2017 and a 52 week low of Rs. 329.95 on 26-Dec-2016.

Last one week high and low of the scrip stood at Rs. 454.60 and Rs. 438.05 respectively. The current market cap of the company is Rs. 45781.77 crore.

The promoters holding in the company stood at 74.79%, while institutions and non-institutions held 17.28% and 7.93% respectively.

Cadila Healthcare's wholly owned subsidiary -- Zydus Pharmaceuticals (USA) has received the final approval from the United States Food & Drug Administration (USFDA) to market Minocycline Hydrochloride Extended-Release Tablets in strengths of 45 mg, 80 mg, 90 mg, 105 mg, and 135 mg. Zydus also received the tentative approval for Minocycline Hydrochloride Extended-Release Tablets, 55 mg, 65 mg, and 115 mg.

Minocycline Hydrochloride Extended-Release Tablets are a tetracycline-class drug, indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. It will be produced at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 170 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


Related News

View all news

HDFC trades higher on the bourses

Housing Development Finance Corporation is currently trading at Rs. 1921.45, up by 1.40 points or 0.07% from its previous closing of Rs. 1920.05 on the BSE.The scrip opened at Rs. 1919.70 and has touched......

GAIL rises on planning to invest in start-ups, solar power plants, battery charging stations

GAIL (India) is currently trading at Rs. 382.70, up by 3.60 points or 0.95% from its previous closing of Rs. 379.10 on the BSE.The scrip opened at Rs. 378.25 and has touched a high and low of Rs. 386.85......

InterGlobe Aviation rises on reporting passenger load factor of 88.7% in July

Interglobe Aviation is currently trading at Rs. 1088.45, up by 2.70 points or 0.25% from its previous closing of Rs. 1085.75 on the BSE.The scrip opened at Rs. 1075.00 and has touched a high and low of......

Top News

View all news

Uday Jewellery commences manufacturing activities at Hyderabad unit

Uday Jewellery Industries has commenced the manufacturing activities in premises situated at Hyderabad taken on lease for enhancement of its manufacturing capabilities for manufacture of specialty jewellery......

Strides Shasun's arm receives acceptance from USFDA for two key ANDAs

Strides Shasun's step-down wholly owned subsidiary, Strides Pharma Global, Singapore has received Abbreviated New Drug Application (ANDA) “acceptable for filing” correspondence from the United States Food......

IDBI Bank sells 3.90% stake in NSDL

IDBI Bank has sold 15,60,000 equity shares constituting 3.90% of the paid up capital of National Securities Depository (NSDL) on August 21, 2018.IDBI Bank is the youngest, new generation public sector......